Trial · NCT03397446
Registered outcomes27
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
21 to 27 of 27
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Secondary | Percent of binge and purge remission (binge and purge remission rate) | Through study completion, up to two years | Cessation defined as 100% reduction in binge and/or purge episodes in the last 28 days of treatment. |
| Secondary | Change in Clinical Global Impression - Severity Scale (CGI-S) | Screening visit, Week 5, Post (End of week 8) | A 7-point scale that requires the clinician to rate the severity of the patient's illness at time of assessment, relative to the clinician's past experience with patients who have the same diagnosis. |
| Secondary | Change in the Modified Two-Step Task parameters | Week 1, Week 2, Week 5, Week 9 (1-week Follow-up) | As measured by the Modified Two-Step Task. This task examines exploration/exploitation (choice consistency), as well as goal-directed (i.e., model-based) and habitual (i.e., model-free) control. |
| Secondary | Change from baseline in the Coping Self-Efficacy Scale (CSES) | Week 1, Week 5, Post (End of week 8) | A 26-item measure of one's confidence in performing coping behaviors when faced with life challenges. |
| Secondary | Change from baseline in the Locus of Control of Behaviour (LCB) | Week 1, Week 5, Post (End of week 8) | A 17-item measure of the extent to which subjects perceive responsibility for their behaviour. |
| Secondary | Change from baseline in Motivation, Confidence, and Readiness for Behaviour Change Questions | Week 1, Week 5, Post (End of week 8) | A 3-item measure that assesses the perceived value of changing binge eating, confidence in ability to change binge eating, and readiness to change binge eating. |
| Secondary | Qualitative Patient Experience Interview | Week 5, Week 9 (1-week Follow-up) | An exploratory interview which aims to collect qualitative information on each patient's experiences with the study medication (i.e., from the patient's perspective, how does the medication affect their eating disorder symptoms?). |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03397446/registered?page=2